Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy Adults

12. november 2026 oppdatert av: Driscoll's

This is a decentralized, single-arm, within-subject crossover clinical study evaluating the effects of Driscoll's Raspberries and Driscoll's Blackberries on postprandial glycemic response, satiety, and consumer appeal in healthy adults aged 18-65 years. Forty participants will each consume three standardized breakfast meals - a raspberry-inclusive meal, a blackberry-inclusive meal, and a sugar-reference meal - in any order over a two-week period, wearing a continuous glucose monitor (CGM) throughout.

All study activities are conducted remotely at participants' homes. CGM data will be used to compute incremental area under the glucose-time curve (iAUC) over the two-hour postprandial window following each meal. Self-reported questionnaires will assess satiety, energy, digestive comfort, and sensory appeal following each meal condition.

Studieoversikt

Status

Har ikke rekruttert ennå

Studietype

Intervensjonell

Registrering (Antatt)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Nevada
      • Las Vegas, Nevada, Forente stater, 89101
        • Citruslabs

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Be male or female.
  • Adult aged 18-65 years.
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
  • Willing and able to wear a CGM device continuously for the two-week study period.
  • Willing to consume three standardized breakfast meals over the two-week study period, each consumed after an overnight fast of at least eight hours, with a minimum of 24 hours between each standardized meal event.
  • Willing to purchase and eat fresh Driscoll's Raspberries and Driscoll's Blackberries from a local retailer using a sponsor-provided berry stipend for use in the standardized meals.
  • Have reasonable access to a retailer that sells Driscoll's-branded raspberries and blackberries.
  • Have access to a smartphone or computer with a reliable internet connection.
  • Willing to maintain the same diet and exercise regimen consistently throughout the study duration.
  • Willing and able to complete all required digital surveys via the Citruslabs study platform at Baseline, and at the end of the day following Meal 1, Meal 2, and Meal 3.
  • Resides in the United States.

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
  • Anyone currently undergoing treatment for cancer, or have had a serious illness requiring hospitalization in the last 3 months.
  • Known or suspected allergy or hypersensitivity to raspberries, blackberries, or other berry species.
  • Known or suspected allergy, intolerance, or sensitivity to oats or gluten that would prevent consumption of the standardized oat-based meal component.
  • Current diagnosis of type 1 diabetes, type 2 diabetes, or prediabetes.
  • Current use of any medications or supplements known to significantly affect blood glucose levels, including but not limited to: insulin, metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, sulfonylureas, or other glucose-lowering agents.
  • Known skin sensitivity to adhesives or prior documented adverse reaction to CGM sensors or similar transcutaneous monitoring devices.
  • Presence of implanted electronic devices (e.g., pacemaker, implantable cardioverter-defibrillator) that may be contraindicated with CGM device use, per the CGM manufacturer's specifications.
  • Pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Anyone with a history of substance abuse.
  • Anyone who is currently a smoker or has been a smoker in the past three months.
  • Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.
  • History of an eating disorder currently requiring active clinical treatment.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Driscoll's Blackberries Arm

All participants complete all three meal conditions in any sequence.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Incremental Area Under the Glucose-Time Curve (iAUC) - Raspberry Meal vs. Sugar-Reference Meal
Tidsramme: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of raspberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
Incremental Area Under the Glucose-Time Curve (iAUC) - Blackberry Meal vs. Sugar-Reference Meal
Tidsramme: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of blackberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Self-Reported Hunger
Tidsramme: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Fullness
Tidsramme: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Desire to Eat
Tidsramme: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Energy Levels
Tidsramme: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Digestive Comfort
Tidsramme: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Bloating
Tidsramme: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Perceived Sweetness of Meal
Tidsramme: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Palatability of Meal
Tidsramme: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Motivation to Eat Healthier the Rest of the Day
Tidsramme: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Overall Acceptability of Meal
Tidsramme: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

1. desember 2026

Studiet fullført (Antatt)

1. desember 2026

Datoer for studieregistrering

Først innsendt

12. november 2026

Først innsendt som oppfylte QC-kriteriene

12. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • DRISC-40019

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere